Could a mushroom-derived product be the future of lung cancer prevention?

Researchers find that a mushroom-derived product, GLSF, shows promise in reducing lung toxicity and tumor development induced by tobacco smoke carcinogens in mice. The study opens the door for future clinical trials, potentially offering a natural preventive measure against lung cancer.

Very Early Abortion Non-Inferior to Standard Medication Abortion Timing

Initiating medication abortion early was just as effective as standard medication abortion timing, an international randomized controlled trial found. Intention-to-treat analysis revealed that complete abortion

November 7, 2024

This fall’s COVID booster faces a new subvariant

Good morning Pharmalittle students. This is Allison DeAngelis, filling in for Ed Silverman while he’s away from the Pharmalot campus. I debated assigning you a

August 25, 2023

New Formula Leverages Proenkephalin A 119-159 (penKid) for Improved GFR Estimation in Steady-State and Critically Ill Patients – Biotech Investments

Issuer: SphingoTec GmbH / Key word(s): Research Update/Study results 05.10.2023 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. PenKid

October 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.